Search Results
Found 1 results
510(k) Data Aggregation
(43 days)
K-ASSAY ALPHA-1 AG
The K-ASSAY Alpha-1 AG Assay is intended to be used for the quantitative determination of Alpha-1 AG in human serum by immunoturbidimetric assay. Measurement of Alpha-1 AG may aid in the diagnosis of collagen (connective tissue) disorders, tuberculosis, infections, extensive malignancy, and diabetes. FOR IN VITRO DIAGNOSTIC USE.
Not Found
The provided text is a 510(k) clearance letter from the FDA for a device named "K-ASSAY Alpha-1 AG." This document outlines the regulatory approval for an in vitro diagnostic device and does not contain information about acceptance criteria or specific study results that would typically be associated with an AI/ML-driven device.
Therefore, I cannot fulfill your request as the necessary information (acceptance criteria, device performance, sample sizes, expert qualifications, adjudication methods, MRMC studies, standalone performance, ground truth details, or training set information) is not present in the provided text.
The document states:
- Device Name: K-ASSAY Alpha-1 AG.
- Intended Use: "The K-ASSAY Alpha-1 AG Assay is intended to be used for the quantitative determination of Alpha-1 AG in human serum by immunoturbidimetric assay. Measurement of Alpha-1 AG may aid in the diagnosis of collagen (connective tissue) disorders, tuberculosis, infections, extensive malignancy, and diabetes. FOR IN VITRO DIAGNOSTIC USE."
- Regulatory Clearance: Substantial equivalence to a predicate device.
To address your request, I would need a document that describes the clinical performance study of a device, usually found in a clinical study report or a 510(k) summary for devices that rely on quantitative or qualitative performance metrics against defined acceptance criteria.
Ask a specific question about this device
Page 1 of 1